NCT04948541

Brief Summary

Aims of this research are to detect if an improvement in sleep pattern in patients suffering from obstructive sleep apnea (OSA), produces a reduction in pain and dysfunction in the orofacial area by examining variation in temporo-mandibular disorder (TMD) signs and symptoms and if the prevalence of TMDs in OSA patients controlling this disease decreases to levels comparable to healthy subjects. 41 OSA patients will undergo a complete TMD examination prior to start any OSA treatment and after at least 18 months of therapy. Variations in TMD signs and symptoms will be recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 21, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2021

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 2, 2021

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2021

Completed
Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

June 17, 2021

Last Update Submit

March 16, 2026

Conditions

Keywords

painsleep apneatemporo-mandibular disorders

Outcome Measures

Primary Outcomes (1)

  • variation in TMD prevalence according to diagnostic criteria for temporo-mandibular disorders

    prevalence described as percentage of people having the disease

    change from baseline temporo-mandibular disorders at 18 months

Secondary Outcomes (2)

  • change in TMD signs according to diagnostic criteria for temporo-mandibular disorder

    change from baseline temporo-mandibular disorder signs at 18 months

  • change in TMD symptoms according to diagnostic criteria for temporo-mandibular disorder

    change from baseline temporo-mandibular disorder symptoms at 18 months

Study Arms (2)

treatment

EXPERIMENTAL
Combination Product: osa treatment

no treatment

EXPERIMENTAL
Other: no treatment

Interventions

osa treatmentCOMBINATION_PRODUCT

different treatments can be included

treatment

no treatment was undergone

no treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients suffering from OSA diagnosed by polysomnography not yet undergoing treatment

You may not qualify if:

  • patients presenting some kind of cognitive impairment, due to difficulties in undergoing TMD examination
  • patients presenting dental problems
  • patients assuming medications that would alter pain perception
  • patients not signing the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico Universitario A. Gemelli IRCCS

Roma, RM, 00168, Italy

Location

Related Publications (1)

  • Alessandri-Bonetti A, Lobbezoo F, Mangino G, Aarab G, Gallenzi P. Obstructive sleep apnea treatment improves temporomandibular disorder pain. Sleep Breath. 2024 Mar;28(1):203-209. doi: 10.1007/s11325-023-02883-4. Epub 2023 Jul 25.

MeSH Terms

Conditions

Sleep Apnea SyndromesSleep Apnea, ObstructivePainFacial PainTemporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCraniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 17, 2021

First Posted

July 2, 2021

Study Start

April 21, 2021

Primary Completion

June 30, 2021

Study Completion

July 15, 2021

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations